Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Kantarjian, Hagop, Stein, Anthony, Gökbuget, Nicola, Fielding, Adele K, Schuh, Andre C, Ribera, Josep-Maria, Wei, Andrew, Dombret, Hervé, Foà, Robin, Bassan, Renato, Arslan, Önder, Sanz, Miguel A, Bergeron, Julie, Demirkan, Fatih, Lech-Maranda, Ewa, Rambaldi, Alessandro, Thomas, Xavier, Horst, Heinz-August, Brüggemann, Monika, Klapper, Wolfram, Wood, Brent L, Fleishman, Alex, Nagorsen, Dirk, Holland, Christopher, Zimmerman, Zachary, Topp, Max S
Published in The New England journal of medicine (02.03.2017)
Published in The New England journal of medicine (02.03.2017)
Get full text
Journal Article
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia
Montesinos, Pau, Recher, Christian, Vives, Susana, Zarzycka, Ewa, Wang, Jianxiang, Bertani, Giambattista, Heuser, Michael, Calado, Rodrigo T, Schuh, Andre C, Yeh, Su-Peng, Daigle, Scott R, Hui, Jianan, Pandya, Shuchi S, Gianolio, Diego A, de Botton, Stephane, Döhner, Hartmut
Published in The New England journal of medicine (21.04.2022)
Published in The New England journal of medicine (21.04.2022)
Get full text
Journal Article
A 17-gene stemness score for rapid determination of risk in acute leukaemia
Ng, Stanley W. K., Mitchell, Amanda, Kennedy, James A., Chen, Weihsu C., McLeod, Jessica, Ibrahimova, Narmin, Arruda, Andrea, Popescu, Andreea, Gupta, Vikas, Schimmer, Aaron D., Schuh, Andre C., Yee, Karen W., Bullinger, Lars, Herold, Tobias, Görlich, Dennis, Büchner, Thomas, Hiddemann, Wolfgang, Berdel, Wolfgang E., Wörmann, Bernhard, Cheok, Meyling, Preudhomme, Claude, Dombret, Hervé, Metzeler, Klaus, Buske, Christian, Löwenberg, Bob, Valk, Peter J. M., Zandstra, Peter W., Minden, Mark D., Dick, John E., Wang, Jean C. Y.
Published in Nature (London) (15.12.2016)
Published in Nature (London) (15.12.2016)
Get full text
Journal Article
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine
Pollyea, Daniel A, Pratz, Keith W, Wei, Andrew H, Pullarkat, Vinod, Jonas, Brian A, Recher, Christian, Babu, Sunil, Schuh, Andre C, Dail, Monique, Sun, Yan, Potluri, Jalaja, Chyla, Brenda, DiNardo, Courtney D
Published in Clinical cancer research (15.12.2022)
Published in Clinical cancer research (15.12.2022)
Get full text
Journal Article
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Dombret, Hervé, Seymour, John F., Butrym, Aleksandra, Wierzbowska, Agnieszka, Selleslag, Dominik, Jang, Jun Ho, Kumar, Rajat, Cavenagh, James, Schuh, Andre C., Candoni, Anna, Récher, Christian, Sandhu, Irwindeep, Bernal del Castillo, Teresa, Al-Ali, Haifa Kathrin, Martinelli, Giovanni, Falantes, Jose, Noppeney, Richard, Stone, Richard M., Minden, Mark D., McIntyre, Heidi, Songer, Steve, Lucy, Lela M., Beach, C.L., Döhner, Hartmut
Published in Blood (16.07.2015)
Published in Blood (16.07.2015)
Get full text
Journal Article
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
DiNardo, Courtney D, Schuh, Andre C, Stein, Eytan M, Montesinos, Pau, Wei, Andrew H, de Botton, Stéphane, Zeidan, Amer M, Fathi, Amir T, Kantarjian, Hagop M, Bennett, John M, Frattini, Mark G, Martin-Regueira, Patricia, Lersch, Frederik, Gong, Jing, Hasan, Maroof, Vyas, Paresh, Döhner, Hartmut
Published in The lancet oncology (01.11.2021)
Published in The lancet oncology (01.11.2021)
Get full text
Journal Article
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine
Pratz, Keith W, Jonas, Brian A, Pullarkat, Vinod, Recher, Christian, Schuh, Andre C, Thirman, Michael J, Garcia, Jacqueline S, DiNardo, Courtney D, Vorobyev, Vladimir, Fracchiolla, Nicola S, Yeh, Su-Peng, Jang, Jun Ho, Ozcan, Muhit, Yamamoto, Kazuhito, Illes, Arpad, Zhou, Ying, Dail, Monique, Chyla, Brenda, Potluri, Jalaja, Döhner, Hartmut
Published in Journal of clinical oncology (10.03.2022)
Published in Journal of clinical oncology (10.03.2022)
Get full text
Journal Article
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
DiNardo, Courtney D, Stein, Anthony S, Stein, Eytan M, Fathi, Amir T, Frankfurt, Olga, Schuh, Andre C, Döhner, Hartmut, Martinelli, Giovanni, Patel, Prapti A, Raffoux, Emmanuel, Tan, Peter, Zeidan, Amer M, de Botton, Stéphane, Kantarjian, Hagop M, Stone, Richard M, Frattini, Mark G, Lersch, Frederik, Gong, Jing, Gianolio, Diego A, Zhang, Vickie, Franovic, Aleksandra, Fan, Bin, Goldwasser, Meredith, Daigle, Scott, Choe, Sung, Wu, Bin, Winkler, Thomas, Vyas, Paresh
Published in Journal of clinical oncology (01.01.2021)
Published in Journal of clinical oncology (01.01.2021)
Get full text
Journal Article
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, Liran I., Zandi, Sasan, Mitchell, Amanda, Chen, Weihsu Claire, Brandwein, Joseph M., Gupta, Vikas, Kennedy, James A., Schimmer, Aaron D., Schuh, Andre C., Yee, Karen W., McLeod, Jessica L., Doedens, Monica, Medeiros, Jessie J. F., Marke, Rene, Kim, Hyeoung Joon, Lee, Kwon, McPherson, John D., Hudson, Thomas J., Pan-Leukemia Gene Panel Consortium, The HALT, Brown, Andrew M. K., Yousif, Fouad, Trinh, Quang M., Stein, Lincoln D., Minden, Mark D., Wang, Jean C. Y., Dick, John E.
Published in Nature (London) (20.02.2014)
Published in Nature (London) (20.02.2014)
Get full text
Journal Article
Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status
Roboz, Gail J., Ravandi, Farhad, Wei, Andrew H., Dombret, Hervé, Thol, Felicitas, Voso, Maria Teresa, Schuh, Andre C., Porkka, Kimmo, La Torre, Ignazia, Skikne, Barry, Zhong, Jianhua, Beach, C.L., Risueño, Alberto, Menezes, Daniel L., Ossenkoppele, Gert, Döhner, Hartmut
Published in Blood (07.04.2022)
Published in Blood (07.04.2022)
Get full text
Journal Article
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
de Botton, Stéphane, Montesinos, Pau, Schuh, Andre C., Papayannidis, Cristina, Vyas, Paresh, Wei, Andrew H., Ommen, Hans, Semochkin, Sergey, Kim, Hee-Je, Larson, Richard A., Koprivnikar, Jaime, Frankfurt, Olga, Thol, Felicitas, Chromik, Jörg, Byrne, Jenny, Pigneux, Arnaud, Thomas, Xavier, Salamero, Olga, Vidriales, Maria Belen, Doronin, Vadim, Döhner, Hartmut, Fathi, Amir T., Laille, Eric, Yu, Xin, Hasan, Maroof, Martin-Regueira, Patricia, DiNardo, Courtney D.
Published in Blood (12.01.2023)
Published in Blood (12.01.2023)
Get full text
Journal Article
Time to repeal and replace response criteria for acute myeloid leukemia?
Bloomfield, Clara Derber, Estey, Elihu, Pleyer, Lisa, Schuh, Andre C., Stein, Eytan M., Tallman, Martin S., Wei, Andrew
Published in Blood reviews (01.09.2018)
Published in Blood reviews (01.09.2018)
Get full text
Journal Article
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Topp, Max S., Zimmerman, Zachary, Cannell, Paul, Dombret, Hervé, Maertens, Johan, Stein, Anthony, Franklin, Janet, Tran, Qui, Cong, Ze, Schuh, Andre C.
Published in Blood (28.06.2018)
Published in Blood (28.06.2018)
Get full text
Journal Article
Azacitidine in adult patients with acute myeloid leukemia
Schuh, Andre C, Döhner, Hartmut, Pleyer, Lisa, Seymour, John F, Fenaux, Pierre, Dombret, Hervé
Published in Critical reviews in oncology/hematology (01.08.2017)
Published in Critical reviews in oncology/hematology (01.08.2017)
Get full text
Journal Article
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia
Murphy, Tracy, Zou, Jinfeng, Arruda, Andrea, Wang, Ting Ting, Zhao, Zhen, Zheng, Yangqiao, Gupta, Vikas, Maze, Dawn, McNamara, Caroline, Minden, Mark D, Schimmer, Aaron, Sibai, Hassan, Yee, Karen, Capo-Chichi, Jose-Mario, Stockley, Tracy, Schuh, Andre, Bratman, Scott V, Chan, Steven M
Published in Haematologica (Roma) (01.02.2024)
Published in Haematologica (Roma) (01.02.2024)
Get full text
Journal Article
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
Pleyer, Lisa, Döhner, Hartmut, Dombret, Hervé, Seymour, John F, Schuh, Andre C, Beach, C L, Swern, Arlene S, Burgstaller, Sonja, Stauder, Reinhard, Girschikofsky, Michael, Sill, Heinz, Schlick, Konstantin, Thaler, Josef, Halter, Britta, Machherndl Spandl, Sigrid, Zebisch, Armin, Pichler, Angelika, Pfeilstöcker, Michael, Autzinger, Eva M, Lang, Alois, Geissler, Klaus, Voskova, Daniela, Sperr, Wolfgang R, Hojas, Sabine, Rogulj, Inga M, Andel, Johannes, Greil, Richard
Published in International journal of molecular sciences (15.02.2017)
Published in International journal of molecular sciences (15.02.2017)
Get full text
Journal Article
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia
Dombret, Hervé, Topp, Max S., Schuh, Andre C., Wei, Andrew H., Durrant, Simon, Bacon, Christopher Larry, Tran, Qui, Zimmerman, Zachary, Kantarjian, Hagop
Published in Leukemia & lymphoma (29.07.2019)
Published in Leukemia & lymphoma (29.07.2019)
Get full text
Journal Article